TY - JOUR
T1 - Integrated respiratory chemoreflex‐mediated regulation of cerebral blood flow in hypoxia: Implications for oxygen delivery and acute mountain sickness
AU - Ogoh, Shigehiko
AU - Washio, Takuro
AU - Stacey, Benjamin S.
AU - Tsukamoto, Hayato
AU - Iannetelli, Angelo
AU - Owens, Thomas S.
AU - Calverley, Thomas A.
AU - Fall, Lewis
AU - Marley, Christopher J
AU - Saito, Shotaro
AU - Watanabe, Hironori
AU - Hashimoto, Takeshi
AU - Ando, Soichi
AU - Miyamoto, Tadayoshi
AU - Bailey, Damian M.
N1 - © 2021 The Authors. Experimental Physiology © 2021 The Physiological Society.
PY - 2021/7/27
Y1 - 2021/7/27
N2 - The aim of the present study was to determine to what extent hypoxia-induced changes in the peripheral and central respiratory chemoreflex modulate anterior and posterior cerebral blood flow (CBF), oxygen delivery (CDO2) and corresponding implications for the pathophysiology of the neurological syndrome, acute mountain sickness (AMS). Eight healthy males were randomly assigned single-blind to 7 h passive exposure to both normoxia (21% O2) and hypoxia (12% O2). The peripheral and central respiratory chemoreflex, internal carotid (ICA), external carotid (ECA), and vertebral (VA) artery blood flow (duplex ultrasound) and AMS scores (questionnaires) were measured throughout. A reduction in ICA CDO2 was observed during hypoxia despite a compensatory elevation in perfusion. In contrast, VA and ECA CDO2 were preserved that in the former was due to a more marked increase in perfusion. Hypoxia was associated with progressive activation of the peripheral respiratory chemoreflex (P <0.001) whereas the central respiratory chemoreflex remained unchanged (P >0.05). Symptom severity in participants who developed clinical AMS was positively related to ECA blood flow (LLS, r = 0.546∼0.709, P = 0.004∼0.043; ESQ-C, r = 0.587∼0.771, P = 0.001∼0.027, n = 4). Collectively, these findings highlight the site-specific regulation of CBF in hypoxia that selectively maintains CDO2 in the posterior but not anterior cerebral circulation, with minimal contribution from the central respiratory chemoreflex. Furthermore, ECA vasodilation may represent a hitherto unexplored hemodynamic risk factor implicated in the pathophysiology of AMS.
AB - The aim of the present study was to determine to what extent hypoxia-induced changes in the peripheral and central respiratory chemoreflex modulate anterior and posterior cerebral blood flow (CBF), oxygen delivery (CDO2) and corresponding implications for the pathophysiology of the neurological syndrome, acute mountain sickness (AMS). Eight healthy males were randomly assigned single-blind to 7 h passive exposure to both normoxia (21% O2) and hypoxia (12% O2). The peripheral and central respiratory chemoreflex, internal carotid (ICA), external carotid (ECA), and vertebral (VA) artery blood flow (duplex ultrasound) and AMS scores (questionnaires) were measured throughout. A reduction in ICA CDO2 was observed during hypoxia despite a compensatory elevation in perfusion. In contrast, VA and ECA CDO2 were preserved that in the former was due to a more marked increase in perfusion. Hypoxia was associated with progressive activation of the peripheral respiratory chemoreflex (P <0.001) whereas the central respiratory chemoreflex remained unchanged (P >0.05). Symptom severity in participants who developed clinical AMS was positively related to ECA blood flow (LLS, r = 0.546∼0.709, P = 0.004∼0.043; ESQ-C, r = 0.587∼0.771, P = 0.001∼0.027, n = 4). Collectively, these findings highlight the site-specific regulation of CBF in hypoxia that selectively maintains CDO2 in the posterior but not anterior cerebral circulation, with minimal contribution from the central respiratory chemoreflex. Furthermore, ECA vasodilation may represent a hitherto unexplored hemodynamic risk factor implicated in the pathophysiology of AMS.
KW - hypoxia
KW - cerebral blood flow
KW - oxygen delivery
KW - respiratory chemoreflex
KW - acute mountain sickness
U2 - 10.1113/ep089660
DO - 10.1113/ep089660
M3 - Article
C2 - 34318560
SN - 0958-0670
VL - 106
SP - 1922
EP - 1938
JO - Experimental Physiology
JF - Experimental Physiology
IS - 9
M1 - EP089660
ER -